{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:55:38Z","timestamp":1777874138037,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/06522-2"],"award-info":[{"award-number":["2018\/06522-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/23864-7"],"award-info":[{"award-number":["2019\/23864-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/09022\\u20138"],"award-info":[{"award-number":["2017\/09022\\u20138"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/17177\\u20136"],"award-info":[{"award-number":["2015\/17177\\u20136"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/17177"],"award-info":[{"award-number":["2015\/17177"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.tiv.2021.105207","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:34:30Z","timestamp":1625099670000},"page":"105207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells"],"prefix":"10.1016","volume":"76","author":[{"given":"Catarina Sofia Mateus","family":"Reis-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Cristina","family":"Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keli","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Lima","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Roberto Hrihorowitsch","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia Veras","family":"Costa-Lotufo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2021.105207_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4314\/epj.v30i1.5","article-title":"In vitro antimicrobial activity of a semi-synthetic derivative of embelin","volume":"30","author":"Bisrat","year":"2014","journal-title":"Ethiop. Pharm. J."},{"key":"10.1016\/j.tiv.2021.105207_bb0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2013.04.018","article-title":"XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells","volume":"37","author":"Carter","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.tiv.2021.105207_bb0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41419-020-02972-2","article-title":"Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tiv.2021.105207_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.csbj.2019.01.009","article-title":"Targeting the BIR domains of inhibitor of apoptosis (IAP) proteins in cancer treatment","volume":"17","author":"Cossu","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tiv.2021.105207_bb0025","first-page":"191","article-title":"The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway","volume":"55","author":"Coyle","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tiv.2021.105207_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tiv.2021.105207_bb0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tiv.2021.105207_bb0040","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-020-01944-5","article-title":"A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia","volume":"98","author":"Kirtonia","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.tiv.2021.105207_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","article-title":"Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia","volume":"10","author":"Konopleva","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tiv.2021.105207_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/COC.0000000000000099","article-title":"Randomized phase II study of the X-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC)","volume":"39","author":"Lee","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.tiv.2021.105207_bib121","article-title":"Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax","author":"Lima","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.tiv.2021.105207_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11523-019-00638-4","article-title":"Venetoclax synergistically enhances the anti-leukemic activity of vosaroxin against acute myeloid leukemia cells ex vivo","volume":"14","author":"Liu","year":"2019","journal-title":"Target. Oncol."},{"key":"10.1016\/j.tiv.2021.105207_bb0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.tiv.2021.105207_bb0065","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.18632\/oncotarget.2016","article-title":"XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells","volume":"5","author":"Moreno-Martinez","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.tiv.2021.105207_bb0070","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1021\/jm030420+","article-title":"Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database","volume":"47","author":"Nikolovska-Coleska","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2021.105207_bb0075","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/s12885-020-07469-x","article-title":"Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine","volume":"20","author":"Nishi","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tiv.2021.105207_bb0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0031-9422(00)84831-1","article-title":"Hydroxybenzoquinones from Myrsinaceae plants \u2013 II. Distribution among Myrsinaceae plants in Japan","volume":"7","author":"Ogawa","year":"1968","journal-title":"Phytochemistry"},{"key":"10.1016\/j.tiv.2021.105207_bb0085","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tiv.2021.105207_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180895","article-title":"Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase\/AKT signaling by embelin suppresses growth of leukemic cells","volume":"12","author":"Prabhu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2021.105207_bb0095","first-page":"424","article-title":"XIAP (X-linked inhibitor of apoptosis)","volume":"24","author":"Reis-Silva","year":"2020","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"10.1016\/j.tiv.2021.105207_bb0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.tiv.2021.105207_bb0105","doi-asserted-by":"crossref","first-page":"562558","DOI":"10.3389\/fonc.2020.562558","article-title":"Venetoclax-based combinations in acute myeloid leukemia: current evidence and future directions","volume":"10","author":"Samra","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tiv.2021.105207_bb0110","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1200\/JCO.2009.21.8172","article-title":"Phase I\/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia","volume":"27","author":"Schimmer","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tiv.2021.105207_bb0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.tiv.2021.105207_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12013-014-0197-9","article-title":"Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-kappaB inactivation","volume":"71","author":"Yang","year":"2015","journal-title":"Cell Biochem. Biophys."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233321001326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233321001326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:08:35Z","timestamp":1777576115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233321001326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":25,"alternative-id":["S0887233321001326"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105207","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105207"}}